☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
NeoImmuneTech
NeoImmuneTech’s NT-I7 (efineptakin alfa) Receives the US FDA Orphan Drug Designation for the Treatment of Glioblastoma Multiforme
July 13, 2022
Load more...
Back to Home